Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2002
10/16/2002CN1374112A New prepn process of Zhuanglong as one traditional Mongolian medicine
10/16/2002CN1374111A New prepn process of Manu as one traditional Mongolian medicine
10/16/2002CN1374086A Neutrocyte functional inhibitor
10/16/2002CN1092712C Process for producing human C36/C46 receptor (CR1) polypeptide
10/16/2002CN1092642C Quinoline derivatives as tachykinin NK 3 receptor antagonists
10/16/2002CN1092640C Imides as PDE III, PDE IV and TNF inhibitors
10/16/2002CA2406401A1 Process for preparation of sulfonamide derivatives and crystals thereof
10/15/2002USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents
10/15/2002US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/15/2002US6465518 2-amino-5-fluoro-6-(1-iminoethylamino)-hept-4-enoic acid, for example; treating or preventing various causes of inflammation
10/15/2002US6465511 Treatment of septic shock
10/15/2002US6465509 Pyrones as inhibitors of cyclooxygenase-2
10/15/2002US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002US6465483 Treating or preventing strokes; chronic inflammatory disorders such as bronchial asthma and arthritis; antiproliferative effect; ulcerative colitis and crohn's disease
10/15/2002US6465478 Analgesics, antiinflammatories, diuretics, anesthetics, neuroprotective agents, antihypertensive or antianxiety agent, appetite control, hearing regulation
10/15/2002US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002US6465471 Cinnamic acid derivatives
10/15/2002US6465470 R-hydroxynefazodone
10/15/2002US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002US6465455 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/15/2002US6465444 Protein tyrosine phosphatases(ptp-1b); antidiabetic, antitumor and anorexigenic agents; combination therapy
10/15/2002US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002US6465424 Comprising a purified polypeptide the amino acid sequence of which comprises the pre-activation domain from plasminogen and at least one kringle from plasminogen
10/15/2002US6465231 GSK3 polypeptides
10/15/2002US6465187 Inhibition of gene expression of antiapoptotic genes to treat mast cell mediated inflammatory disorders
10/15/2002US6465003 Drug delivery
10/15/2002US6464987 Pharmaceutical compositions capable of being gelled
10/15/2002US6464986 Method for treating pain by peripheral administration of a neurotoxin
10/15/2002CA2253795C Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
10/15/2002CA2145211C The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
10/15/2002CA2063521C Tacky, hydrophilic gel dressings and products therefrom
10/10/2002WO2002079517A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002WO2002079448A2 G-protein coupled receptors
10/10/2002WO2002079441A2 Secreted proteins
10/10/2002WO2002079256A1 Antibody and utilization thereof
10/10/2002WO2002079248A2 Mammalian alpha-helical protein-53
10/10/2002WO2002079236A1 Alpha conotoxin peptides with analgesic properties
10/10/2002WO2002079199A1 Thiophene derivatives and use thereof
10/10/2002WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002WO2002079194A1 Ccr5 antagonists useful for treating aids
10/10/2002WO2002079190A1 3-substituted indoles as chemokine antagonists
10/10/2002WO2002079188A1 Pyrrolidine sulfonamides
10/10/2002WO2002079170A2 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing them
10/10/2002WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079162A1 Carboxylic acids
10/10/2002WO2002079157A1 Aryl oxime-piperazines useful as ccr5 antagonists
10/10/2002WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002WO2002079155A1 Pyrrolidine sulfonamides
10/10/2002WO2002079154A1 Substituted carbazoles as inhibitors of spla2
10/10/2002WO2002079152A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002WO2002079151A1 3-substituted indoels or fused pyrroles as antagonists of the chemokine mcp-1 (ccr2b) receptor
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002078766A2 Combination therapy
10/10/2002WO2002078747A2 Pregabalin lactose conjugates
10/10/2002WO2002078733A1 Monocyte-specific particulate delivery vehicle
10/10/2002WO2002078730A2 Use of neublastin polypeptides for treating neuropathic pain
10/10/2002WO2002078724A1 Biologically active aqueous fraction of an extract obtained from a mangrove plant salvadora persica l.
10/10/2002WO2002078705A1 Hsp inductor
10/10/2002WO2002078699A1 Compounds and methods
10/10/2002WO2002078697A1 Compounds and methods
10/10/2002WO2002078696A1 Compounds and methods
10/10/2002WO2002078684A2 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
10/10/2002WO2002078683A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002WO2002078682A2 Estrogen replacement therapy
10/10/2002WO2002078680A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002WO2002078643A2 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002WO2002078640A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002WO2002078627A2 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
10/10/2002WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078615A2 Antioxidant nitroxides and nitrones as therapeutic agents
10/10/2002WO2002078445A1 Formulations comprising entrapped active ingredients and uses thereof
10/10/2002WO2002060386A3 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
10/10/2002WO2002058636A3 Novel cannabimimetic ligands
10/10/2002WO2002053516A3 N(phenylsulphonyl)glycine derivatives and their therapeutic use
10/10/2002WO2002046373A8 Method of collecting placental stem cells
10/10/2002WO2002046178A3 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors
10/10/2002WO2002032406A3 Methods and products related to pulmonary delivery of polysaccharides
10/10/2002WO2002024706A3 Water soluble rapamycin esters
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001095929A3 Interferon for treatment of multiple sclerosis
10/10/2002WO2001093852A3 Method of treating pain using nalbuphine and opioid antagonists
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002US20020147339 5-cyano-2-aminopyrimidine derivatives
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147238 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using R(-)-ketoprofen
10/10/2002US20020147233 Epoxyvibsanin B
10/10/2002US20020147231 Allosteric adenosine receptor modulators
10/10/2002US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/10/2002US20020147222 Brain disorders; Alzheimer's disease
10/10/2002US20020147221 Cyclooxygenase inhibitors; antiinflammatory agents
10/10/2002US20020147205 Heterocyclic compounds
10/10/2002US20020147203 Tyrosine kinase inhibitors
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147188 Protease inhibitors
10/10/2002US20020147185 Antihypoxic agents, antiischamic agents, antiarrhythmia agents
1 ... 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 ... 1272